Author: TechBrunch
Apple on Wednesday rolled out the latest developer beta releases of its top operating systems, including iOS 18.2, iPadOS 18.2, and macOS Sequoia 15.2. These releases arrive one week before the general availability of iOS 18.1, iPadOS 18.1, and macOS Sequoia 15.1, although Apple has not yet specified a date. Next week's release will mark the first time Apple Intelligence features are generally available in non-beta form. These include integrated writing tools, image cleanup, article summaries, and typing input for a redesigned Siri experience. Those of you brave enough to sign up for the developer beta program now will have…
Developers got their first taste of Apple Intelligence's ChatGPT integration on Wednesday, thanks to the newly released iOS 18.2, iPadOS 18.2, and macOS Sequoia 15.2 updates. This integration will occur in parallel with other Apple Intelligence features such as Genmoji, Image Playground, Visual Intelligence, and Image Wand. For the first time, the public has access to Apple Intelligence features such as integrated writing tools, image cleanup, article summaries, and input input in the redesigned Siri experience in iOS 18.1, iPadOS 18.1, and 15.1 releases It will be. However, you will have to wait for future updates to access OpenAI's platform.…
Four months after announcing Apple Intelligence, the company's generative AI service is finally available to the public. The platform is scheduled to be released at an unspecified date next week as part of the public versions of iOS 18.1, iPadOS 18.1, and macOS Sequoia 15.1. Most rumors are that these operating system upgrades are expected to debut on Monday. Portions of Apple Intelligence are available to users running developer beta versions of the aforementioned operating systems. These include integrated writing tools, image cleanup, article summaries, and typing input for a redesigned Siri experience. Apple on Wednesday began rolling out developer…
Apple on Wednesday released developer beta versions of iOS 18.2, iPadOS 18.2, and macOS Sequoia 15.2, delivering new Apple Intelligence features including Genmoji, Image Playground, Visual Intelligence, Image Wand, and ChatGPT integration. The software update was delivered the week before the general availability of OS 18.1, iPadOS 18.1, and macOS Sequoia 15.1 and brings writing tools, image cleanup, article summarization, and input input to the platform for a redesigned Siri experience. Masu. In addition to these updates, we've also added APIs for three key Apple Intelligence features: Writing Tools API, Genmoji API, and Image Playground API. All of this is…
DuckDuckGo, the privacy-focused search service that replaces Google, wants to put money into similarly privacy-focused startups. The company says it is actively seeking startups seeking investment or interested in partnering with or acquiring companies. In today's blog post, the company identified Mike Marino, senior vice president of finance, and Diana Chiu, director of corporate and business development, as points of contact for anyone interested. DuckDuckGo writes: “For early-stage investments, we are flexible in our deal structures, aim to move quickly, and are happy to co-invest with other companies, funds, and individuals.When it comes to acquisitions, we protect your privacy. We…
Google is making generally available SynthID Text, a technology that allows developers to watermark and detect text written by generative AI models. SynthID Text can be downloaded from the AI platform Hugging Face and Google's updated Responsible GenAI Toolkit. “We are open sourcing the SynthID Text watermarking tool,” the company said in a post on Ta. So how does it work? Given a prompt like “What's your favorite fruit?”, the text generation model will tell you which “token” is most likely to follow another one token at a time. Predict each. A token is a single character or word and…
With TechCrunch Disrupt 2024 less than a week away, we’re thrilled to announce the complete list of companies behind the Side Events, set to amplify the excitement for thousands of attendees and Silicon Valley residents. From casual happy hours to insightful discussions and energizing morning runs, Disrupt Week — spanning October 26 to November 1 — features an exciting mix of Side Events happening across San Francisco, organized by a diverse collection of innovative companies. Side Event guidelines and disclaimers Registering/RSVPing to a Side Event does not grant you access/ticket/badge to TechCrunch Disrupt 2024, taking place October 28-30. Each event…
Top US technology giants such as Amazon, Microsoft, Google, Meta, and Apple have deep pockets, enough to spend tens of billions of dollars on AI development and infrastructure. Next on the list are leading companies such as OpenAI, Anthropic, and xAI, which are spending billions of dollars on AI. And there are a few challengers like Mistral and Eleven Labs capable of spending hundreds of millions of dollars. But how long can these challengers keep up? And can they surpass the giants? Phillippe Botteri, an Accel partner who has led investments in companies such as DocuSign, UiPath, and more recently…
With TechCrunch Disrupt 2024 just days away, we’re gearing up for an incredible three-day event packed with interactive sessions! From October 28-30 at Moscone West in San Francisco, dive into Q&A conversations with a panel of industry experts around the most pressing issues and cutting-edge tech trends to help empower your growth. Don’t miss your chance to save and engage in these first come, first served Breakouts! Register now to lock in up to $400 in savings on select tickets before door prices increase. Want to bring a friend? Take advantage of the Expo+ 2-for-1 Pass and bring a plus-one…
The first thing Promise Bio CEO Ronel Veksler wants you to know about the biotech company he co-founded is that it's not just another AI drug discovery company. Instead, he's bringing precision medicine to autoimmune diseases. Tel Aviv-based Promise Bio has developed a cloud-based AI platform that can detect various post-translational modifications (PTMs) of proteins from a single blood sample. Before Promise's technology, identifying one of these 200 protein modifications required a separate test. These PTMs are key to the diagnosis and treatment of diseases such as autoimmune diseases. “It's very substantial, it's like going from a black and white…